Nanotis Corporation announced that it expects to receive funding from Taisho Pharmaceutical Holdings Co., Ltd., Hamamatsu Photonics K.K., Nissha Co., Ltd.
On the same date, the company has received funding from new investor Taisho Pharmaceutical Holdings Co., Ltd. (TSE:4581) in its first tranche. The company will continue to raise funds from institutional and individual investors.